The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive ...
2h
Hosted on MSNIMNN: Phase 3 Ovarian Cancer Trial to get Underway in Mar 2025…IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Phase 3 Ovarian Cancer Trial to Initiate in March 2025 Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial ...
Columvi plus chemotherapy showed a 41% reduction in the risk of death in the pivotal phase III STARGLO study 1,2 ; DLBCL-an ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the RedChip Small Stocks, Big Money™ show, a sponsored ...
Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell ...
BEIJING -- Chinese scientists have identified a cytokine produced by tumor cells as the key factor driving irreversible fat ...
Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results